Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient (ContraCHECK)

Nantes University Hospital (NUH)

Status: Completed

Conditions: Emergency

Treatments: Other: contrast product used to assess biomarkers variations

Study type: Observational

Funder types: Other

Identifiers

NCT02881710

RC14_0241

Details and patient eligibility

About

Multicenter, prospective, uncontrolled study to evaluate variations in urinary concentrations of TIMP-2 and PCI IGFBP7 induced injection during a CT scan in intensive care patient.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients aged 18 years or more,
• Hospitalized in intensive care,
• Holders of a urinary catheter
• Patient receiving a first CT with intravenous injection of PCI during their ICU stay.
• Patient agreeing to participate in the research protocol

Exclusion criteria

• Anuria
• Need to retain urine, whatever the reason (eg measurement of 24-hour proteinuria).
• Urine unanalyzable whatever reason (eg urinary washing with double current probe, injection is saline to measure bladder pressure.).
• Patient subjected to renal replacement
• Patient already included in the study for a previous injection of PCI in intensive care.